Loading...
XJPX
7792
Market cap79mUSD
Jul 10, Last price  
1,455.00JPY
1D
0.69%
1Q
3.49%
IPO
-9.29%
Name

Colan Totte Co Ltd

Chart & Performance

D1W1MN
XJPX:7792 chart
P/E
9.84
P/S
1.89
EPS
147.90
Div Yield, %
2.91%
Shrs. gr., 5y
2.67%
Rev. gr., 5y
19.10%
Revenues
6.92b
+16.37%
2,926,271,0002,887,366,0003,714,902,0004,663,759,0005,406,535,0005,944,680,0006,917,910,000
Net income
1.33b
+29.65%
271,329,000324,810,000420,505,000610,454,000645,017,0001,024,431,0001,328,215,000
CFO
998m
+12.96%
115,698,000378,765,000637,266,000148,095,000955,698,000883,766,000998,346,000
Dividend
Sep 29, 202644 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Colan Totte Co., Ltd., established in Osaka, Japan, in 1997, operates as an international firm specializing in the development and global distribution of therapeutic devices under its proprietary Colantotte brand. The company's diverse product portfolio features an array of magnetic therapy items for domestic use, including specialized necklaces designed to alleviate neck and shoulder discomfort, loop-style products for arm support, various general joint supporters, performance-enhancing recovery apparel, and magnetic pillows. In addition to these physical goods, they also offer sleep-enhancing supplements. Furthermore, Colan Totte manages the Colantotte Safety System, an emergency notification service accessible via a unique card, pendant, or keychain. Their sales strategy incorporates wholesale partnerships, directly managed retail outlets, and a comprehensive online platform.
IPO date
Jul 08, 2021
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT